Filing Details

Accession Number:
0001179110-20-010667
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-23 19:53:47
Reporting Period:
2020-10-21
Accepted Time:
2020-10-23 19:53:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203342 Robert Auciaux 3838 West Parkway Blvd
Salt Lake City UT 84120
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-21 426 $0.00 1,543 No 4 M Direct
Common Stock Disposition 2020-10-21 128 $81.50 1,415 No 4 F Direct
Common Stock Disposition 2020-10-23 989 $85.29 426 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2020-10-21 426 $0.00 426 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
852 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
  2. Restricted Stock Units vest 25% on July 22, 2020, October 21, 2020, February 10, 2021, and April 28,2021.